SHADOW HEALTH: PHARMACOLOGY INTERMEDIATE PATIENT CASE EXAM
— 2026/2027
EXACT OFFICIAL COUNT: 50 QUESTIONS
Complete Exam-Style Questions with Detailed Rationales | 100% Verified | Graded A+
Shadow Health Pharmacology Unguided Intermediate Patient Case Examination – Comprehensive
Clinical Pharmacotherapeutics Competency Assessment for Nursing Students (Shadow Health Digital
Clinical Experiences™ / NCSBN Clinical Judgment Measurement Model Alignment) | Core Domains:
Medication Safety & High-Alert Protocols, Pharmacokinetics/Pharmacodynamics Application,
Cardiovascular & Respiratory Pharmacotherapy, Neurologic & Psychiatric Medication Management,
Endocrine & Metabolic Pharmacotherapy, Anti-Infectives & Antimicrobial Stewardship, and NGN
Clinical Judgment Application in Virtual Patient Scenarios | Shadow Health Pharmacology–Aligned
Format
────────────────────────────────────────
• Exam Format: 50 Multiple-Choice Questions (MCQ)
• Testing Time: 90 minutes (computer-based simulation format)
• Passing Score: 80% or higher (40/50 correct)
• Item Types: Standard MCQ, Select-All-That-Apply (SATA), NGN Bow-Tie, Trend Recognition,
Matrix Multiple-Choice, Virtual Patient Prioritization Scenarios, Dosage Calculation Application,
and Clinical Judgment Application Questions
• Assessment Alignment: NCSBN Clinical Judgment Measurement Model (CJMM), Shadow
Health Digital Clinical Experiences™, NCSBN NGN Test Plan
Abstract
This Shadow Health Pharmacology Intermediate Patient Case Exam format for 2026 reflects the
standardized competency assessment used to evaluate proficiency in applied clinical
pharmacotherapeutic principles for nursing students progressing through intermediate pharmacology
education. The official examination consists of exactly 50 multiple-choice questions (MCQ) covering
critical domains: medication safety and high-alert protocols, pharmacokinetics/pharmacodynamics
application, cardiovascular and respiratory pharmacotherapy, neurologic and psychiatric medication
management, endocrine and metabolic pharmacotherapy, anti-infectives and antimicrobial
stewardship, and NGN clinical judgment application in virtual patient scenarios. The exam measures
knowledge essential for safe, effective, and evidence-based medication management practice in
simulated clinical environments, aligned with current NCSBN Clinical Judgment Measurement Model
(CJMM), Shadow Health Digital Clinical Experiences™ learning objectives, NCSBN NGN test plan,
and institutional nursing program pharmacology competencies. This practice assessment includes
comprehensive rationales for each question, clinical pharmacotherapeutic decision-making
frameworks, and CJMM step integration to support deep learning and clinical judgment development.
Keywords: Shadow Health, Pharmacology, Intermediate Patient Case, Clinical
Pharmacotherapeutics, Medication Safety, NCSBN CJMM, NGN Clinical Judgment, Virtual Patient
Scenarios, Antimicrobial Stewardship, Nursing Education
Introduction
This Shadow Health Pharmacology Intermediate Patient Case Exam format for 2026 reflects the
standardized competency assessment used to evaluate proficiency in applied clinical
pharmacotherapeutic principles for nursing students progressing through intermediate pharmacology
education. The official examination consists of exactly 50 multiple-choice questions (MCQ) covering
critical domains: medication safety and high-alert protocols, pharmacokinetics/pharmacodynamics
application, cardiovascular and respiratory pharmacotherapy, neurologic and psychiatric medication
,management, endocrine and metabolic pharmacotherapy, anti-infectives and antimicrobial
stewardship, and NGN clinical judgment application in virtual patient scenarios. The exam measures
knowledge essential for safe, effective, and evidence-based medication management practice in
simulated clinical environments, aligned with current NCSBN Clinical Judgment Measurement Model
(CJMM), Shadow Health Digital Clinical Experiences™ learning objectives, NCSBN NGN test plan,
and institutional nursing program pharmacology competencies. Each question is designed to test not
only pharmacological knowledge but also the ability to apply clinical reasoning within the CJMM
framework—recognizing cues, analyzing cues, prioritizing hypotheses, generating solutions, taking
action, and evaluating outcomes—in the context of virtual patient care scenarios.
Examination Overview
Domain Questions Key Topics Weight
Medication Safety & High-Alert 10 Rights of Medication 20%
Protocols Administration, BCMA, Double-
Checks, ISMP Guidelines, High-
Alert Medications
(Insulin/Heparin/Opioids), Error
Prevention in Virtual Scenarios
Pharmacokinetics/Pharmacodynamics 8 ADME Processes in Virtual 16%
Application Patients, Half-Life Calculations,
Therapeutic Drug Monitoring, Drug
Interactions, Receptor Theory
Application in Case Scenarios
Cardiovascular & Respiratory 9 Antihypertensives, Antianginals, 18%
Pharmacotherapy Anticoagulants, Bronchodilators,
Corticosteroids, Monitoring
Parameters in Virtual Patient Cases
Neurologic & Psychiatric Medication 8 Antidepressants, Antipsychotics, 16%
Management Anticonvulsants, Anxiolytics,
Opioids, Side Effect Monitoring,
Serotonin Syndrome/NMS
Recognition in Virtual Cases
Endocrine & Metabolic 7 Insulin Types/Dosing, Oral 14%
Pharmacotherapy Antidiabetics, Thyroid Medications,
Corticosteroids,
Hypoglycemia/Hyperglycemia
Management in Virtual Patient
Scenarios
Anti-Infectives & Antimicrobial 5 Antibiotics, Antivirals, Antifungals, 10%
Stewardship Resistance Prevention, Allergy
Assessment, Culture-Guided
Therapy in Virtual Cases
NGN Clinical Judgment Application 3 Bow-Tie Items, Trend Recognition, 6%
Matrix Matching, CJMM
Integration, Virtual Patient
Prioritization, Comprehensive
Pharmacotherapy Decision-Making
TOTAL 50 Comprehensive Clinical 100%
Pharmacology Competency
, Examination Questions
Domain: Medication Safety & High-Alert Protocols
This domain assesses the nurse's ability to implement and evaluate medication safety protocols for
high-alert medications in virtual patient scenarios. Questions focus on the rights of medication
administration, barcode medication administration (BCMA) technology, independent double-checks,
ISMP high-alert medication guidelines, smart pump dose error reduction systems, look-alike/sound-
alike (LASA) medication differentiation, and medication error reporting procedures. Emphasis is
placed on applying the CJMM framework to prioritize patient safety in pharmacological
interventions.
1. In the Shadow Health virtual patient case, Tina Jones is prescribed insulin glargine 20
units subcutaneously at bedtime. Which action should the nurse prioritize BEFORE
administration?
A. Verify the insulin type, dose, and patient identity using two identifiers, and perform an
independent double-check with another licensed nurse per facility policy for high-alert
medications
B. Administer the insulin immediately to maintain the prescribed schedule
C. Check the patient's blood glucose and hold the dose if >200 mg/dL
D. Document the administration in the electronic health record before giving the medication
Correct Answer: A
Rationale: Insulin is a high-alert medication requiring enhanced safety measures. The priority
action is verification of the five rights (patient, drug, dose, route, time) using two identifiers, plus an
independent double-check with another licensed nurse per ISMP and facility policy. Administering
immediately (B) bypasses critical safety checks. Holding for glucose >200 mg/dL (C) is incorrect—
glargine is a basal insulin not held for hyperglycemia. Documenting before administration (D) is
illegal and dangerous. This scenario tests the "Take Action" step of the CJMM framework for high-
alert medication safety in virtual patient contexts.
2. Select All That Apply: Which actions demonstrate adherence to the "Five Rights" of
medication administration in the Shadow Health virtual patient environment?
(Select All That Apply)
A. Verifying the virtual patient's identity using two identifiers before accessing the medication
B. Checking the medication label against the virtual MAR three times (before removal, before
preparation, before administration)
C. Administering the medication via the prescribed route at the correct time in the simulation
D. Documenting administration in the virtual EHR immediately after giving the medication
Correct Answer: A,B,C,D
Rationale: The Five Rights (right patient, drug, dose, route, time) are foundational to medication
safety. In Shadow Health simulations: verifying identity (A) ensures right patient; triple-checking
the label (B) ensures right drug/dose; administering via prescribed route/time (C) ensures right
route/time; documenting after administration (D) completes the legal and safety record. All actions
align with ISMP safety standards and reduce preventable medication errors in both virtual and
clinical practice. Shadow Health cases reinforce these principles through deliberate practice.
3. The nurse in a Shadow Health simulation is preparing to administer heparin 5,000
units subcutaneously. Which safety measure is most critical before administration?
A. Verify the concentration on the vial label matches the MAR order and perform an independent
double-check with a second nurse
B. Ask the patient if they have taken heparin before
C. Administer the dose in the deltoid muscle for faster absorption
D. Apply a warm compress to the injection site before administration
Correct Answer: A
Rationale: Heparin is an ISMP-designated high-alert medication requiring independent double-
checks and concentration verification due to multiple available concentrations that have led to fatal
overdoses. Verifying concentration and performing a double-check (A) are critical safety measures.
— 2026/2027
EXACT OFFICIAL COUNT: 50 QUESTIONS
Complete Exam-Style Questions with Detailed Rationales | 100% Verified | Graded A+
Shadow Health Pharmacology Unguided Intermediate Patient Case Examination – Comprehensive
Clinical Pharmacotherapeutics Competency Assessment for Nursing Students (Shadow Health Digital
Clinical Experiences™ / NCSBN Clinical Judgment Measurement Model Alignment) | Core Domains:
Medication Safety & High-Alert Protocols, Pharmacokinetics/Pharmacodynamics Application,
Cardiovascular & Respiratory Pharmacotherapy, Neurologic & Psychiatric Medication Management,
Endocrine & Metabolic Pharmacotherapy, Anti-Infectives & Antimicrobial Stewardship, and NGN
Clinical Judgment Application in Virtual Patient Scenarios | Shadow Health Pharmacology–Aligned
Format
────────────────────────────────────────
• Exam Format: 50 Multiple-Choice Questions (MCQ)
• Testing Time: 90 minutes (computer-based simulation format)
• Passing Score: 80% or higher (40/50 correct)
• Item Types: Standard MCQ, Select-All-That-Apply (SATA), NGN Bow-Tie, Trend Recognition,
Matrix Multiple-Choice, Virtual Patient Prioritization Scenarios, Dosage Calculation Application,
and Clinical Judgment Application Questions
• Assessment Alignment: NCSBN Clinical Judgment Measurement Model (CJMM), Shadow
Health Digital Clinical Experiences™, NCSBN NGN Test Plan
Abstract
This Shadow Health Pharmacology Intermediate Patient Case Exam format for 2026 reflects the
standardized competency assessment used to evaluate proficiency in applied clinical
pharmacotherapeutic principles for nursing students progressing through intermediate pharmacology
education. The official examination consists of exactly 50 multiple-choice questions (MCQ) covering
critical domains: medication safety and high-alert protocols, pharmacokinetics/pharmacodynamics
application, cardiovascular and respiratory pharmacotherapy, neurologic and psychiatric medication
management, endocrine and metabolic pharmacotherapy, anti-infectives and antimicrobial
stewardship, and NGN clinical judgment application in virtual patient scenarios. The exam measures
knowledge essential for safe, effective, and evidence-based medication management practice in
simulated clinical environments, aligned with current NCSBN Clinical Judgment Measurement Model
(CJMM), Shadow Health Digital Clinical Experiences™ learning objectives, NCSBN NGN test plan,
and institutional nursing program pharmacology competencies. This practice assessment includes
comprehensive rationales for each question, clinical pharmacotherapeutic decision-making
frameworks, and CJMM step integration to support deep learning and clinical judgment development.
Keywords: Shadow Health, Pharmacology, Intermediate Patient Case, Clinical
Pharmacotherapeutics, Medication Safety, NCSBN CJMM, NGN Clinical Judgment, Virtual Patient
Scenarios, Antimicrobial Stewardship, Nursing Education
Introduction
This Shadow Health Pharmacology Intermediate Patient Case Exam format for 2026 reflects the
standardized competency assessment used to evaluate proficiency in applied clinical
pharmacotherapeutic principles for nursing students progressing through intermediate pharmacology
education. The official examination consists of exactly 50 multiple-choice questions (MCQ) covering
critical domains: medication safety and high-alert protocols, pharmacokinetics/pharmacodynamics
application, cardiovascular and respiratory pharmacotherapy, neurologic and psychiatric medication
,management, endocrine and metabolic pharmacotherapy, anti-infectives and antimicrobial
stewardship, and NGN clinical judgment application in virtual patient scenarios. The exam measures
knowledge essential for safe, effective, and evidence-based medication management practice in
simulated clinical environments, aligned with current NCSBN Clinical Judgment Measurement Model
(CJMM), Shadow Health Digital Clinical Experiences™ learning objectives, NCSBN NGN test plan,
and institutional nursing program pharmacology competencies. Each question is designed to test not
only pharmacological knowledge but also the ability to apply clinical reasoning within the CJMM
framework—recognizing cues, analyzing cues, prioritizing hypotheses, generating solutions, taking
action, and evaluating outcomes—in the context of virtual patient care scenarios.
Examination Overview
Domain Questions Key Topics Weight
Medication Safety & High-Alert 10 Rights of Medication 20%
Protocols Administration, BCMA, Double-
Checks, ISMP Guidelines, High-
Alert Medications
(Insulin/Heparin/Opioids), Error
Prevention in Virtual Scenarios
Pharmacokinetics/Pharmacodynamics 8 ADME Processes in Virtual 16%
Application Patients, Half-Life Calculations,
Therapeutic Drug Monitoring, Drug
Interactions, Receptor Theory
Application in Case Scenarios
Cardiovascular & Respiratory 9 Antihypertensives, Antianginals, 18%
Pharmacotherapy Anticoagulants, Bronchodilators,
Corticosteroids, Monitoring
Parameters in Virtual Patient Cases
Neurologic & Psychiatric Medication 8 Antidepressants, Antipsychotics, 16%
Management Anticonvulsants, Anxiolytics,
Opioids, Side Effect Monitoring,
Serotonin Syndrome/NMS
Recognition in Virtual Cases
Endocrine & Metabolic 7 Insulin Types/Dosing, Oral 14%
Pharmacotherapy Antidiabetics, Thyroid Medications,
Corticosteroids,
Hypoglycemia/Hyperglycemia
Management in Virtual Patient
Scenarios
Anti-Infectives & Antimicrobial 5 Antibiotics, Antivirals, Antifungals, 10%
Stewardship Resistance Prevention, Allergy
Assessment, Culture-Guided
Therapy in Virtual Cases
NGN Clinical Judgment Application 3 Bow-Tie Items, Trend Recognition, 6%
Matrix Matching, CJMM
Integration, Virtual Patient
Prioritization, Comprehensive
Pharmacotherapy Decision-Making
TOTAL 50 Comprehensive Clinical 100%
Pharmacology Competency
, Examination Questions
Domain: Medication Safety & High-Alert Protocols
This domain assesses the nurse's ability to implement and evaluate medication safety protocols for
high-alert medications in virtual patient scenarios. Questions focus on the rights of medication
administration, barcode medication administration (BCMA) technology, independent double-checks,
ISMP high-alert medication guidelines, smart pump dose error reduction systems, look-alike/sound-
alike (LASA) medication differentiation, and medication error reporting procedures. Emphasis is
placed on applying the CJMM framework to prioritize patient safety in pharmacological
interventions.
1. In the Shadow Health virtual patient case, Tina Jones is prescribed insulin glargine 20
units subcutaneously at bedtime. Which action should the nurse prioritize BEFORE
administration?
A. Verify the insulin type, dose, and patient identity using two identifiers, and perform an
independent double-check with another licensed nurse per facility policy for high-alert
medications
B. Administer the insulin immediately to maintain the prescribed schedule
C. Check the patient's blood glucose and hold the dose if >200 mg/dL
D. Document the administration in the electronic health record before giving the medication
Correct Answer: A
Rationale: Insulin is a high-alert medication requiring enhanced safety measures. The priority
action is verification of the five rights (patient, drug, dose, route, time) using two identifiers, plus an
independent double-check with another licensed nurse per ISMP and facility policy. Administering
immediately (B) bypasses critical safety checks. Holding for glucose >200 mg/dL (C) is incorrect—
glargine is a basal insulin not held for hyperglycemia. Documenting before administration (D) is
illegal and dangerous. This scenario tests the "Take Action" step of the CJMM framework for high-
alert medication safety in virtual patient contexts.
2. Select All That Apply: Which actions demonstrate adherence to the "Five Rights" of
medication administration in the Shadow Health virtual patient environment?
(Select All That Apply)
A. Verifying the virtual patient's identity using two identifiers before accessing the medication
B. Checking the medication label against the virtual MAR three times (before removal, before
preparation, before administration)
C. Administering the medication via the prescribed route at the correct time in the simulation
D. Documenting administration in the virtual EHR immediately after giving the medication
Correct Answer: A,B,C,D
Rationale: The Five Rights (right patient, drug, dose, route, time) are foundational to medication
safety. In Shadow Health simulations: verifying identity (A) ensures right patient; triple-checking
the label (B) ensures right drug/dose; administering via prescribed route/time (C) ensures right
route/time; documenting after administration (D) completes the legal and safety record. All actions
align with ISMP safety standards and reduce preventable medication errors in both virtual and
clinical practice. Shadow Health cases reinforce these principles through deliberate practice.
3. The nurse in a Shadow Health simulation is preparing to administer heparin 5,000
units subcutaneously. Which safety measure is most critical before administration?
A. Verify the concentration on the vial label matches the MAR order and perform an independent
double-check with a second nurse
B. Ask the patient if they have taken heparin before
C. Administer the dose in the deltoid muscle for faster absorption
D. Apply a warm compress to the injection site before administration
Correct Answer: A
Rationale: Heparin is an ISMP-designated high-alert medication requiring independent double-
checks and concentration verification due to multiple available concentrations that have led to fatal
overdoses. Verifying concentration and performing a double-check (A) are critical safety measures.
